Skip to main content
. 2012 May 9;7(5):e36535. doi: 10.1371/journal.pone.0036535

Figure 4. Evaluation of growth and therapeutic effect by MLuc Viability Assay.

Figure 4

(A) TC2-hMLuc cells and (B) LNCaP-MLuc cells were treated with a 10 micromolar dose of the anti-androgen Bicalutamide (Casodex) or vehicle and viable cell numbers over a given time were evaluated by MTS Assays (N = 8). Y-Axis represents fold MLuc activity relative to time zero. Statistical significance was determine by student'st-test (*p<0.05). Error bars represent the standard error of the mean.